A novel immunoglobulin A nephropathy (IgAN) drug cut proteinuria in half, according to interim findings from the ongoing ...

AstraZeneca targets $80bn revenue by 2030, driven by oncology and new drugs, but faces patent risks and tough competition.

TEM is a data-rich platform that recently clinched a $200 million deal with AstraZeneca. TEM’s main bet is now on AI for ...

It’s the silent, progressive disease that slowly is killing millions of Australians – but most don’t know they have it.

COVID-19 cases rise in India with mild symptoms, no need for mass vaccination, focus on preventive measures emphasized.

Only 25% of AI projects meet ROI goals. IBM argues the solution is strategy-first, not more hype. Learn how to scale AI with ...

More than 240,000 people have signed a petition to ban dog testing ...

In the week ending June 6, 2025, the Indian equity markets posted significant gains, bolstered by a surprise 50 basis points ...

Relations between Saudi Arabia and Sweden are witnessing rapid development with the expansion of cooperation in the fields of ...

Back in 2019, Danielle Jackson packed up her life in Cleveland and headed for a new chapter in Georgia. But just days before ...

Snapping two week losing Streak Sensex surged 737.98 points or 0.90 per cent to settle at 82,188.99 during the week ended ...